The HemoCue® Glucose 201 System is the professional solution for lab-quality glucose testing at the point-of-care. It is intended for the quantitative determination of the instant blood glucose concentration in circulation supplements the clinical evidence in the diagnosis and treatment of patients with diabetes. Features & Benefits:
The HemoCue Glucose Systems are based on a glucose-dehydrogenase method and consist of a small, dedicated analyzer and a unique, disposable microcuvette. They will produce lab-accurate results for diagnosing or monitoring diabetes, as well as monitoring neonatal blood glucose levels.